GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heartseed Inc (TSE:219A) » Definitions » ROCE %

Heartseed (TSE:219A) ROCE % : -28.19% (As of Apr. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Heartseed ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Heartseed's annualized ROCE % for the quarter that ended in Apr. 2024 was -28.19%.


Heartseed ROCE % Historical Data

The historical data trend for Heartseed's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartseed ROCE % Chart

Heartseed Annual Data
Trend Oct22 Oct23
ROCE %
-29.40 -28.35

Heartseed Semi-Annual Data
Oct22 Oct23 Apr24
ROCE % - - -28.19

Heartseed ROCE % Calculation

Heartseed's annualized ROCE % for the fiscal year that ended in Oct. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Oct. 2023 )  (A: Oct. 2022 )(A: Oct. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Oct. 2023 )  (A: Oct. 2022 )(A: Oct. 2023 )
=-1455.838/( ( (4936.004 - 142.395) + (5719.751 - 244.062) )/ 2 )
=-1455.838/( (4793.609+5475.689)/ 2 )
=-1455.838/5134.649
=-28.35 %

Heartseed's ROCE % of for the quarter that ended in Apr. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Apr. 2024 )  (Q: Oct. 2023 )(Q: Apr. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Apr. 2024 )  (Q: Oct. 2023 )(Q: Apr. 2024 )
=-1438.49/( ( (5719.751 - 244.062) + (4965.556 - 235.573) )/ 2 )
=-1438.49/( ( 5475.689 + 4729.983 )/ 2 )
=-1438.49/5102.836
=-28.19 %

(1) Note: The EBIT data used here is two times the semi-annual (Apr. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heartseed  (TSE:219A) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Heartseed ROCE % Related Terms

Thank you for viewing the detailed overview of Heartseed's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartseed Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is engaged in developing and commercializing iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.

Heartseed Headlines

No Headlines